Study Objectives:

To evaluate the impact of COVID-19 pandemic on insomnia and other sleep disturbances in health care professionals.

Methods:

A survey was distributed using social media and organizational emails to Brazilian active health care professionals during the COVID-19 outbreak. We explored potential associated factors including age, gender, occupation, workplace, work hours, income, previous infection with COVID-19, recent/current contact with COVID-19 patients, regional number of incident deaths, anxiety, and burnout. We evaluated new-onset/ previous insomnia worsening episodes (primary outcome), new pharmacological treatments, sleep quality, duration, nightmares and snoring (secondary outcomes).

Results:

A total of 4,384 health professionals from all regions of the country were included in the analysis (44±12 years, 76% females, 53.8% physicians). Overall, 55.7% were assisting patients with COVID-19, and 9.2% had a previous COVID-19 infection. The primary outcome occurred in 32.9% of respondents in parallel to 13% new pharmacological treatments for insomnia. The sleep quality worsened for 61.4%, while 43.5% and 22.8% reported ≥1-hour sleep duration reduction and worsening or new-onset nightmares, respectively. Multivariate analyses showed that age (OR:1.008; 95% CI 1.001-1.015), females (OR:1.590; 95% CI 1.335-1.900), weight change (decrease: OR:1.772; 95% CI 1.453-2.161; increase: OR:1.468; 95% CI 1.249-1.728), prevalent anxiety (OR:3.414; 95% CI 2.954-3.948), new-onset burnout (OR:1.761; 95% CI 1.489-2.083), family income reduction >30% (OR:1.288; 95% CI 1.069-1.553) and assisting patients with COVID-19 (OR:1.275; 95% CI 1.081-1.506) were independently associated with new-onset or worsening of previous insomnia episodes.

Conclusions:

We observed a huge burden of insomnia episodes and other sleep disturbances in health care professionals during the COVID-19 pandemic.

中文翻译：

---

COVID-19 大流行期间的失眠发作、新发药物治疗和其他睡眠障碍：一项针对巴西医疗保健专业人员的全国性横断面研究

学习目标：

评估 COVID-19 大流行对医疗保健专业人员失眠和其他睡眠障碍的影响。

方法：

在 COVID-19 爆发期间，使用社交媒体和组织电子邮件向巴西活跃的医疗保健专业人员分发了一项调查。我们探讨了潜在的相关因素，包括年龄、性别、职业、工作场所、工作时间、收入、以前感染过 COVID-19、最近/当前接触过 COVID-19 患者、地区事件死亡人数、焦虑和倦怠。我们评估了新发/既往失眠恶化事件（主要结果）、新的药物治疗、睡眠质量、持续时间、噩梦和打鼾（次要结果）。

结果：

共有来自全国所有地区的 4,384 名卫生专业人员被纳入分析（44±12 岁，76% 为女性，53.8% 为医生）。总体而言，55.7% 的人正在协助 COVID-19 患者，9.2% 的人曾感染过 COVID-19。主要结果发生在 32.9% 的受访者中，同时 13% 的新药物治疗失眠。睡眠质量恶化了 61.4%，而 43.5% 和 22.8% 的人分别报告了 1 小时以上的睡眠时间减少和恶化或新发的噩梦。多变量分析显示年龄（OR：1.008；95% CI 1.001-1.015）、女性（OR：1.590；95% CI 1.335-1.900）、体重变化（减少：OR：1.772；95% CI 1.453-2.161；增加： OR：1.468；95% CI 1.249-1.728），普遍焦虑（OR：3.414；95% CI 2.954-3.948），新发倦怠（OR：1.761；95% CI 1.489-2.083），家庭收入减少>30% （或：1。288; 95% CI 1.069-1.553）和协助 COVID-19 患者（OR：1.275；95% CI 1.081-1.506）与新发或先前失眠发作的恶化独立相关。

结论：

在 COVID-19 大流行期间，我们观察到医疗保健专业人员的失眠发作和其他睡眠障碍的巨大负担。